Clinical Trial

PPG vs. ICG in Gastrointestinal Resections

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 18, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This randomized controlled trial compares a novel optical technique against the standard of care for assessing tissue perfusion in gastrointestinal surgery. Participants are randomized to receive either intraoperative imaging photoplethysmography (iPPG) or indocyanine green (ICG) fluorescence imaging. In the ICG group, the fluorescence data are comprehensively analyzed in two distinct ways: (1) Qualitative Assessment: real-time visual interpretation of the angiogram flow by the operating surgeon; and (2) Quantitative Assessment: software-based analysis of fluorescence kinetics (e.g., time-to-peak, maximum intensity) to generate objective perfusion parameters. The study aims to determine the agreement between the iPPG-based evaluations and both the qualitative and quantitative dimensions of the ICG standard.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-13; most recent amendment 2025-11-14.
Trial Details
NCT Number NCT06222645
Lead Sponsor Saint Petersburg State University, Russia
Collaborators: Shandong Linglong Yingcheng Hospital, High-Tech Clinic Beloostrov
Conditions Anastomosis, Perfusion, Postoperative Complications, Gastrointestinal Neoplasms, Gastric Cancer (GC), Colorectal Cancer
Enrollment 200 participants
Start Date 2023-11-01
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-18